Follow the people · Insider
Harlan S. Robins
Harlan S. Robins files insider transactions with the SEC as a chief scientific officer of Adaptive Biotechnologies (ADPT). We hold 11 disclosed purchases and sales filed since 3 July 2019, 4 of them in the last 90 days.
- Files forADPT
- Disclosed buys and sells11 in all, 4 in the last 90 days
- Last disclosure23 July 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 1 July 2019 — 21 July 2026Chief Scientific Officer · Adaptive Biotechnologies (ADPT)327 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 284,800 shares of Adaptive BiotechnologiesSEC Form 423 July 2026Common Stock · traded 21 July 2026 · filed 23 July 2026
- ▼ sold on the open market 278,698 shares of Adaptive BiotechnologiesSEC Form 423 July 2026Common Stock · traded 21 July 2026 · filed 23 July 2026
- ▼ sold on the open market 213,702 shares of Adaptive BiotechnologiesSEC Form 423 July 2026Common Stock · traded 21 July 2026 · filed 23 July 2026
- exercised options over 284,800 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 423 July 2026Stock Option (right to buy) · traded 21 July 2026 · filed 23 July 2026
- ▼ sold on the open market 239,351 shares of Adaptive BiotechnologiesSEC Form 47 July 2026Common Stock · traded 2 July 2026 · filed 7 July 2026
- ▼ sold on the open market 146,889 shares of Adaptive BiotechnologiesSEC Form 47 July 2026Common Stock · traded 2 July 2026 · filed 7 July 2026
- ▼ sold on the open market 100,000 shares of Adaptive BiotechnologiesSEC Form 417 June 2026Common Stock · traded 15 June 2026 · filed 17 June 2026
- ▼ sold on the open market 6,160 shares of Adaptive BiotechnologiesSEC Form 417 June 2026Common Stock · traded 16 June 2026 · filed 17 June 2026
- ▼ sold on the open market 10,000 shares of Adaptive BiotechnologiesSEC Form 410 April 2026Common Stock · traded 8 April 2026 · filed 10 April 2026
- ▼ sold on the open market 140,666 shares of Adaptive BiotechnologiesSEC Form 413 March 2026Common Stock · traded 11 March 2026 · filed 13 March 2026
- ▼ sold on the open market 329,600 shares of Adaptive BiotechnologiesSEC Form 413 March 2026Common Stock · traded 11 March 2026 · filed 13 March 2026
- ▼ sold on the open market 140,666 shares of Adaptive BiotechnologiesSEC Form 413 March 2026Common Stock · traded 11 March 2026 · filed 13 March 2026
- ▼ sold on the open market 329,600 shares of Adaptive BiotechnologiesSEC Form 413 March 2026Common Stock · traded 11 March 2026 · filed 13 March 2026
- was granted 127,813 shares of Adaptive BiotechnologiesSEC Form 46 March 2026Common Stock · traded 4 March 2026 · filed 6 March 2026
- was granted 709,220 shares of Adaptive BiotechnologiesSEC Form 46 March 2026Common Stock · traded 6 March 2026 · filed 6 March 2026
- was granted 127,813 shares of Adaptive BiotechnologiesSEC Form 46 March 2026Common Stock · traded 4 March 2026 · filed 6 March 2026
- was granted 709,220 shares of Adaptive BiotechnologiesSEC Form 46 March 2026Common Stock · traded 6 March 2026 · filed 6 March 2026
- ▼ sold on the open market 10,000 shares of Adaptive BiotechnologiesSEC Form 44 March 2026Common Stock · traded 2 March 2026 · filed 4 March 2026
- ▼ sold on the open market 14,233 shares of Adaptive BiotechnologiesSEC Form 44 March 2026Common Stock · traded 3 March 2026 · filed 4 March 2026
- ▼ sold on the open market 10,000 shares of Adaptive BiotechnologiesSEC Form 44 March 2026Common Stock · traded 2 March 2026 · filed 4 March 2026
- ▼ sold on the open market 14,233 shares of Adaptive BiotechnologiesSEC Form 44 March 2026Common Stock · traded 3 March 2026 · filed 4 March 2026
- ▼ sold on the open market 34,668 shares of Adaptive BiotechnologiesSEC Form 44 February 2026Common Stock · traded 2 February 2026 · filed 4 February 2026
- ▼ sold on the open market 8,120 shares of Adaptive BiotechnologiesSEC Form 44 February 2026Common Stock · traded 3 February 2026 · filed 4 February 2026
- ▼ sold on the open market 34,668 shares of Adaptive BiotechnologiesSEC Form 44 February 2026Common Stock · traded 2 February 2026 · filed 4 February 2026
- ▼ sold on the open market 8,120 shares of Adaptive BiotechnologiesSEC Form 44 February 2026Common Stock · traded 3 February 2026 · filed 4 February 2026
- ▼ sold on the open market 10,000 shares of Adaptive BiotechnologiesSEC Form 48 January 2026Common Stock · traded 6 January 2026 · filed 8 January 2026
- ▼ sold on the open market 10,000 shares of Adaptive BiotechnologiesSEC Form 48 January 2026Common Stock · traded 6 January 2026 · filed 8 January 2026
- ▼ sold on the open market 27,212 shares of Adaptive BiotechnologiesSEC Form 45 December 2025Common Stock · traded 3 December 2025 · filed 5 December 2025
- ▼ sold on the open market 10,000 shares of Adaptive BiotechnologiesSEC Form 45 December 2025Common Stock · traded 4 December 2025 · filed 5 December 2025
- ▼ sold on the open market 10,000 shares of Adaptive BiotechnologiesSEC Form 412 November 2025Common Stock · traded 10 November 2025 · filed 12 November 2025
- exercised options over 68,412 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 45 May 2025Stock Option (Right to Buy) · traded 1 May 2025 · filed 5 May 2025
- exercised options over 68,412 shares of Adaptive BiotechnologiesSEC Form 45 May 2025Common Stock · traded 1 May 2025 · filed 5 May 2025
- ▼ sold on the open market 68,412 shares of Adaptive BiotechnologiesSEC Form 45 May 2025Common Stock · traded 1 May 2025 · filed 5 May 2025
- exercised options over 1,698 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 426 March 2025Stock Option (Right to Buy) · traded 24 March 2025 · filed 26 March 2025
- exercised options over 1,698 shares of Adaptive BiotechnologiesSEC Form 426 March 2025Common Stock · traded 24 March 2025 · filed 26 March 2025
- ▼ sold on the open market 1,698 shares of Adaptive BiotechnologiesSEC Form 426 March 2025Common Stock · traded 24 March 2025 · filed 26 March 2025
- was granted 355,000 shares of Adaptive BiotechnologiesSEC Form 46 March 2025Common Stock · traded 4 March 2025 · filed 6 March 2025
- ▼ sold on the open market 40,603 shares of Adaptive BiotechnologiesSEC Form 46 March 2025Common Stock · traded 5 March 2025 · filed 6 March 2025
- ▼ sold on the open market 56,053 shares of Adaptive BiotechnologiesSEC Form 46 March 2025Common Stock · traded 5 March 2025 · filed 6 March 2025
- was granted 354,610 shares of Adaptive BiotechnologiesSEC Form 46 March 2024Common Stock · traded 4 March 2024 · filed 6 March 2024
- was granted 354,610 shares of Adaptive BiotechnologiesSEC Form 48 March 2023Common Stock · traded 6 March 2023 · filed 8 March 2023
- was granted 617,792 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 48 March 2022Stock Option (Right to Buy) · traded 4 March 2022 · filed 8 March 2022
- was granted 247,117 shares of Adaptive BiotechnologiesSEC Form 48 March 2022Common Stock · traded 4 March 2022 · filed 8 March 2022
- ▼ sold on the open market 4,517 shares of Adaptive BiotechnologiesSEC Form 48 March 2022Common Stock · traded 7 March 2022 · filed 8 March 2022
- exercised options over 3,700 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 419 November 2021Stock Option (Right to Buy) · traded 17 November 2021 · filed 19 November 2021
- exercised options over 300 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 419 November 2021Stock Option (Right to Buy) · traded 18 November 2021 · filed 19 November 2021
- exercised options over 3,700 shares of Adaptive BiotechnologiesSEC Form 419 November 2021Common Stock · traded 17 November 2021 · filed 19 November 2021
- ▼ sold on the open market 3,700 shares of Adaptive BiotechnologiesSEC Form 419 November 2021Common Stock · traded 17 November 2021 · filed 19 November 2021
- exercised options over 300 shares of Adaptive BiotechnologiesSEC Form 419 November 2021Common Stock · traded 18 November 2021 · filed 19 November 2021
- ▼ sold on the open market 300 shares of Adaptive BiotechnologiesSEC Form 419 November 2021Common Stock · traded 18 November 2021 · filed 19 November 2021
- exercised options over 3,800 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 421 October 2021Stock Option (Right to Buy) · traded 19 October 2021 · filed 21 October 2021
- exercised options over 3,700 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 421 October 2021Stock Option (Right to Buy) · traded 20 October 2021 · filed 21 October 2021
- exercised options over 3,700 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 421 October 2021Stock Option (Right to Buy) · traded 21 October 2021 · filed 21 October 2021
- exercised options over 3,800 shares of Adaptive BiotechnologiesSEC Form 421 October 2021Common Stock · traded 19 October 2021 · filed 21 October 2021
- ▼ sold on the open market 300 shares of Adaptive BiotechnologiesSEC Form 421 October 2021Common Stock · traded 19 October 2021 · filed 21 October 2021
- ▼ sold on the open market 3,500 shares of Adaptive BiotechnologiesSEC Form 421 October 2021Common Stock · traded 19 October 2021 · filed 21 October 2021
- exercised options over 3,700 shares of Adaptive BiotechnologiesSEC Form 421 October 2021Common Stock · traded 20 October 2021 · filed 21 October 2021
- ▼ sold on the open market 3,700 shares of Adaptive BiotechnologiesSEC Form 421 October 2021Common Stock · traded 20 October 2021 · filed 21 October 2021
- exercised options over 3,700 shares of Adaptive BiotechnologiesSEC Form 421 October 2021Common Stock · traded 21 October 2021 · filed 21 October 2021
- ▼ sold on the open market 3,700 shares of Adaptive BiotechnologiesSEC Form 421 October 2021Common Stock · traded 21 October 2021 · filed 21 October 2021
- exercised options over 3,895 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 48 October 2021Stock Option (Right to Buy) · traded 6 October 2021 · filed 8 October 2021
- exercised options over 3,895 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 48 October 2021Stock Option (Right to Buy) · traded 7 October 2021 · filed 8 October 2021
- exercised options over 3,895 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 48 October 2021Stock Option (Right to Buy) · traded 8 October 2021 · filed 8 October 2021
- exercised options over 3,895 shares of Adaptive BiotechnologiesSEC Form 48 October 2021Common Stock · traded 6 October 2021 · filed 8 October 2021
- ▼ sold on the open market 3,895 shares of Adaptive BiotechnologiesSEC Form 48 October 2021Common Stock · traded 6 October 2021 · filed 8 October 2021
- exercised options over 3,895 shares of Adaptive BiotechnologiesSEC Form 48 October 2021Common Stock · traded 7 October 2021 · filed 8 October 2021
- ▼ sold on the open market 200 shares of Adaptive BiotechnologiesSEC Form 48 October 2021Common Stock · traded 7 October 2021 · filed 8 October 2021
- ▼ sold on the open market 3,695 shares of Adaptive BiotechnologiesSEC Form 48 October 2021Common Stock · traded 7 October 2021 · filed 8 October 2021
- exercised options over 3,895 shares of Adaptive BiotechnologiesSEC Form 48 October 2021Common Stock · traded 8 October 2021 · filed 8 October 2021
- ▼ sold on the open market 3,895 shares of Adaptive BiotechnologiesSEC Form 48 October 2021Common Stock · traded 8 October 2021 · filed 8 October 2021
- exercised options over 3,895 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 415 September 2021Stock Option (Right to Buy) · traded 13 September 2021 · filed 15 September 2021
- exercised options over 3,895 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 415 September 2021Stock Option (Right to Buy) · traded 14 September 2021 · filed 15 September 2021
- exercised options over 3,895 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 415 September 2021Stock Option (Right to Buy) · traded 15 September 2021 · filed 15 September 2021
- exercised options over 3,895 shares of Adaptive BiotechnologiesSEC Form 415 September 2021Common Stock · traded 13 September 2021 · filed 15 September 2021
- ▼ sold on the open market 2,995 shares of Adaptive BiotechnologiesSEC Form 415 September 2021Common Stock · traded 13 September 2021 · filed 15 September 2021
- ▼ sold on the open market 900 shares of Adaptive BiotechnologiesSEC Form 415 September 2021Common Stock · traded 13 September 2021 · filed 15 September 2021
- exercised options over 3,895 shares of Adaptive BiotechnologiesSEC Form 415 September 2021Common Stock · traded 14 September 2021 · filed 15 September 2021
- ▼ sold on the open market 2,795 shares of Adaptive BiotechnologiesSEC Form 415 September 2021Common Stock · traded 14 September 2021 · filed 15 September 2021
- ▼ sold on the open market 1,100 shares of Adaptive BiotechnologiesSEC Form 415 September 2021Common Stock · traded 14 September 2021 · filed 15 September 2021
- exercised options over 3,895 shares of Adaptive BiotechnologiesSEC Form 415 September 2021Common Stock · traded 15 September 2021 · filed 15 September 2021
- ▼ sold on the open market 2,995 shares of Adaptive BiotechnologiesSEC Form 415 September 2021Common Stock · traded 15 September 2021 · filed 15 September 2021
- ▼ sold on the open market 900 shares of Adaptive BiotechnologiesSEC Form 415 September 2021Common Stock · traded 15 September 2021 · filed 15 September 2021
- exercised options over 3,895 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 427 August 2021Stock Option (Right to Buy) · traded 25 August 2021 · filed 27 August 2021
- exercised options over 3,895 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 427 August 2021Stock Option (Right to Buy) · traded 26 August 2021 · filed 27 August 2021
- exercised options over 3,895 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 427 August 2021Stock Option (Right to Buy) · traded 27 August 2021 · filed 27 August 2021
- exercised options over 3,895 shares of Adaptive BiotechnologiesSEC Form 427 August 2021Common Stock · traded 25 August 2021 · filed 27 August 2021
- ▼ sold on the open market 3,895 shares of Adaptive BiotechnologiesSEC Form 427 August 2021Common Stock · traded 25 August 2021 · filed 27 August 2021
- exercised options over 3,895 shares of Adaptive BiotechnologiesSEC Form 427 August 2021Common Stock · traded 26 August 2021 · filed 27 August 2021
- ▼ sold on the open market 3,895 shares of Adaptive BiotechnologiesSEC Form 427 August 2021Common Stock · traded 26 August 2021 · filed 27 August 2021
- exercised options over 3,895 shares of Adaptive BiotechnologiesSEC Form 427 August 2021Common Stock · traded 27 August 2021 · filed 27 August 2021
- ▼ sold on the open market 961 shares of Adaptive BiotechnologiesSEC Form 427 August 2021Common Stock · traded 27 August 2021 · filed 27 August 2021
- ▼ sold on the open market 2,934 shares of Adaptive BiotechnologiesSEC Form 427 August 2021Common Stock · traded 27 August 2021 · filed 27 August 2021
- exercised options over 3,895 shares of Adaptive BiotechnologiesSEC Form 421 July 2021Common Stock · traded 19 July 2021 · filed 21 July 2021
- ▼ sold on the open market 1,273 shares of Adaptive BiotechnologiesSEC Form 421 July 2021Common Stock · traded 19 July 2021 · filed 21 July 2021
- ▼ sold on the open market 2,622 shares of Adaptive BiotechnologiesSEC Form 421 July 2021Common Stock · traded 19 July 2021 · filed 21 July 2021
- exercised options over 3,895 shares of Adaptive BiotechnologiesSEC Form 421 July 2021Common Stock · traded 20 July 2021 · filed 21 July 2021
- ▼ sold on the open market 1,300 shares of Adaptive BiotechnologiesSEC Form 421 July 2021Common Stock · traded 20 July 2021 · filed 21 July 2021
- ▼ sold on the open market 2,595 shares of Adaptive BiotechnologiesSEC Form 421 July 2021Common Stock · traded 20 July 2021 · filed 21 July 2021
- exercised options over 3,895 shares of Adaptive BiotechnologiesSEC Form 421 July 2021Common Stock · traded 21 July 2021 · filed 21 July 2021
- ▼ sold on the open market 1,400 shares of Adaptive BiotechnologiesSEC Form 421 July 2021Common Stock · traded 21 July 2021 · filed 21 July 2021
- ▼ sold on the open market 2,495 shares of Adaptive BiotechnologiesSEC Form 421 July 2021Common Stock · traded 21 July 2021 · filed 21 July 2021
- exercised options over 3,895 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 421 July 2021Stock Option (Right to Buy) · traded 19 July 2021 · filed 21 July 2021
- exercised options over 3,895 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 421 July 2021Stock Option (Right to Buy) · traded 20 July 2021 · filed 21 July 2021
- exercised options over 3,895 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 421 July 2021Stock Option (Right to Buy) · traded 21 July 2021 · filed 21 July 2021
- exercised options over 3,895 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 411 June 2021Stock Option (Right to Buy) · traded 5 May 2021 · filed 11 June 2021
- exercised options over 3,895 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 411 June 2021Stock Option (Right to Buy) · traded 6 May 2021 · filed 11 June 2021
- exercised options over 3,895 shares of Adaptive BiotechnologiesSEC Form 411 June 2021Common Stock · traded 5 May 2021 · filed 11 June 2021
- ▼ sold on the open market 3,895 shares of Adaptive BiotechnologiesSEC Form 411 June 2021Common Stock · traded 5 May 2021 · filed 11 June 2021
- exercised options over 3,895 shares of Adaptive BiotechnologiesSEC Form 411 June 2021Common Stock · traded 6 May 2021 · filed 11 June 2021
- ▼ sold on the open market 3,048 shares of Adaptive BiotechnologiesSEC Form 411 June 2021Common Stock · traded 6 May 2021 · filed 11 June 2021
- ▼ sold on the open market 847 shares of Adaptive BiotechnologiesSEC Form 411 June 2021Common Stock · traded 6 May 2021 · filed 11 June 2021
- exercised options over 3,895 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 411 June 2021Stock Option (Right to Buy) · traded 9 June 2021 · filed 11 June 2021
- exercised options over 3,895 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 411 June 2021Stock Option (Right to Buy) · traded 10 June 2021 · filed 11 June 2021
- exercised options over 3,895 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 411 June 2021Stock Option (Right to Buy) · traded 11 June 2021 · filed 11 June 2021
- exercised options over 3,895 shares of Adaptive BiotechnologiesSEC Form 411 June 2021Common Stock · traded 9 June 2021 · filed 11 June 2021
- ▼ sold on the open market 3,395 shares of Adaptive BiotechnologiesSEC Form 411 June 2021Common Stock · traded 9 June 2021 · filed 11 June 2021
- ▼ sold on the open market 500 shares of Adaptive BiotechnologiesSEC Form 411 June 2021Common Stock · traded 9 June 2021 · filed 11 June 2021
- exercised options over 3,895 shares of Adaptive BiotechnologiesSEC Form 411 June 2021Common Stock · traded 10 June 2021 · filed 11 June 2021
- ▼ sold on the open market 1,100 shares of Adaptive BiotechnologiesSEC Form 411 June 2021Common Stock · traded 10 June 2021 · filed 11 June 2021
- ▼ sold on the open market 2,795 shares of Adaptive BiotechnologiesSEC Form 411 June 2021Common Stock · traded 10 June 2021 · filed 11 June 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.